Argos Therapeutics logo

Argos Therapeutics

A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases

2

Funding Rounds

$67.5m

Money raised

Overview

A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases

Funding

Funding series

Funding Series Analysis

The company Argos Therapeutics has raised a total of $67.5m in funding over 2 rounds.

Key Insights:

  • Argos Therapeutics Series E round: $42.5m
  • Argos Therapeutics Series D round: $25m
Argos Therapeutics logo
Argos Therapeutics Series E round $42.5m
Argos Therapeutics logo
Argos Therapeutics Series D round $25m